Search results
Health officials warn Californians of risks of fake Botox. Here's what to look for
Los Angeles Times· 1 day agoFake versions of Botox have popped up in California, raising alarm among public health officials who...
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 1 day agoFurther, Karuna Therapeutics and Cerevel Therapeutics have shown promise with this mechanism....
REGENXBIO Inc. (NASDAQ:RGNX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoREGENXBIO Inc. (NASDAQ:RGNX) Q1 2024 Earnings Call Transcript May 8, 2024 REGENXBIO Inc. isn’t one...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters via Yahoo Finance· 3 days agoTeva Pharmaceutical Industries said it was set to launch its long awaited biosimilar of AbbVie's...
Regenxbio Inc (RGNX) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress and Robust ...
GuruFocus.com via Yahoo Finance· 2 days agoR&D Expenses: $55 million for Q1 2024, down from $59 million for Q1 2023. Cash Runway Guidance: Expected to fund operations into 2026, excluding potential payments from AbbVie
CDC now says no counterfeit Botox cases in WA
KIRO via Yahoo News· 1 day agoIn a statement released today the Centers for Disease Control and Prevention said there are no illnesses from the counterfeit or mishandled Botox in...
Serum Metabolome Identifies Cancer in Rheumatic Disease
Medscape· 23 hours agoA recent study revealed that alterations in the serum metabolome indicated the presence of...
Health officials warn Californians of risks of fake Botox. Here's what to look for
LA Times via Yahoo News· 1 day agoFake versions of Botox have popped up in California, raising alarm among officials who warn that counterfeit product can lead to slurred speech and breathing issues.
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters· 1 day ago, opens new tab blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months of 2024. In the wake of February's U.S. Food and Drug Administration ...
BellRing Brands (NYSE:BRBR) Receives Buy Rating from Needham & Company LLC
ETF DAILY NEWS· 3 days agoNeedham & Company LLC restated their buy rating on shares of BellRing Brands (NYSE:BRBR – Free Report) in a research report report published on Tuesday, Benzinga reports. Needham & Company LLC ...